Autoimmunity and susceptibility to Hodgkin lymphoma: A population-based case-control study in Scandinavia

被引:163
作者
Landgren, Ola
Engels, Eric A.
Pfeiffer, Ruth M.
Gridley, Gloria
Mellemkjaer, Lene
Olsen, Jorgen H.
Kerstann, Kimberly F.
Wheeler, William
Hemminki, Kari
Linet, Martha S.
Goldin, Lynn R.
机构
[1] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA
[2] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark
[3] Informat Management Serv Inc, Rockville, MD USA
[4] Karolinska Inst, Dept Biosci Novum, Stockholm, Sweden
[5] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany
关键词
D O I
10.1093/jnci/djj361
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Personal history of autoimmune diseases is consistently associated with increased risk of non-Hodgkin lymphoma. In contrast, there are limited data on risk of Hodgkin lymphoma following autoimmune diseases and almost no data addressing whether there is a familial association between the conditions. Methods: Using population-based linked registry data from Sweden and Denmark, 32 separate autoimmune and related conditions were identified from hospital diagnoses in 7476 case subjects with Hodgkin lymphoma, 18 573 matched control subjects, and more than 86 000 first-degree relatives of case and control subjects. We calculated odds ratios (ORs) and 95% confidence intervals (CIs) as measures of relative risks for each condition using logistic regression and also applied multivariable hierarchical regression models. All P values are two-sided. Results: We found statistically significantly increased risks of Hodgkin lymphoma associated with personal histories of several autoimmune conditions, including rheumatoid arthritis (OR = 2.7, 95% CI = 1.9 to 4.0), systemic lupus erythematosus (OR = 5.8, 95% Cl = 2.2 to 15.1), sarcoidosis (OR = 14.1, 95% CI = 5.4 to 36.8), and immune thrombocytopenic purpura (OR = infinity, P = .002). A statistically significant increase in risk of Hodgkin lymphoma was associated with family histories of sarcoidosis (OR = 1.8, 95% CI = 1.01 to 3.1) and ulcerative colitis (OR = 1.6, 95% CI = 1.02 to 2.6). Conclusions: Personal or family history of certain autoimmune conditions was strongly associated with increased risk of Hodgkin lymphoma. The association between both personal and family histories of sarcoidosis and a statistically significantly increased risk of Hodgkin lymphoma suggests shared susceptibility for these conditions.
引用
收藏
页码:1321 / 1330
页数:10
相关论文
共 71 条
[1]  
[Anonymous], 1998, PATIENTREGISTRET 198
[2]   Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists [J].
Askling, J ;
Fored, CM ;
Baecklund, E ;
Brandt, L ;
Backlin, C ;
Ekbom, A ;
Sundström, C ;
Bertilsson, L ;
Cöster, L ;
Geborek, P ;
Jacobsson, LT ;
Lindblad, S ;
Lysholm, J ;
Rantapää-Dahlqvist, S ;
Saxne, T ;
Klareskog, L ;
Feltelius, N .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1414-1420
[3]   Increased risk for cancer following sarcoidosis [J].
Askling, J ;
Grunewald, J ;
Eklund, A ;
Hillerdal, G ;
Ekbom, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) :1668-1672
[4]   Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function [J].
Axdorph, U ;
Porwit-MacDonald, A ;
Sjöberg, J ;
Grimfors, G ;
Ekman, M ;
Wang, W ;
Biberfeld, P ;
Björkholm, M .
BRITISH JOURNAL OF CANCER, 1999, 81 (07) :1182-1187
[5]   Sarcoidosis [J].
Baughman, RP ;
Lower, EE ;
du Bois, RM .
LANCET, 2003, 361 (9363) :1111-1118
[6]   HODGKINS-DISEASE - CASE CONTROL EPIDEMIOLOGIC-STUDY IN YORKSHIRE [J].
BERNARD, SM ;
CARTWRIGHT, RA ;
DARWIN, CM ;
RICHARDS, IDG ;
ROBERTS, B ;
OBRIEN, C ;
BIRD, CC .
BRITISH JOURNAL OF CANCER, 1987, 55 (01) :85-90
[7]   Non-Hodgkin's lymphoma in systemic lupus erythematosus [J].
Bernatsky, S ;
Ramsey-Goldman, R ;
Rajan, R ;
Boivin, JF ;
Joseph, L ;
Lachance, S ;
Cournoyer, D ;
Zoma, A ;
Manzi, S ;
Ginzler, E ;
Urowitz, M ;
Gladman, D ;
Fortin, PR ;
Edworthy, S ;
Barr, S ;
Gordon, C ;
Bae, SC ;
Sibley, J ;
Steinsson, K ;
Nived, O ;
Sturfelt, G ;
St Pierre, Y ;
Clarke, A .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1507-1509
[8]  
Bierman PJ, 1996, ANN ONCOL, V7, P265
[9]  
Björnådal L, 2002, SCAND J RHEUMATOL, V31, P66
[10]   The genetics of inflammatory bowel disease [J].
Bonen, DK ;
Cho, JH .
GASTROENTEROLOGY, 2003, 124 (02) :521-536